0 209

Cited 0 times in

LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)

DC Field Value Language
dc.date.accessioned2023-06-02T00:38:39Z-
dc.date.available2023-06-02T00:38:39Z-
dc.date.issued2022-11-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194324-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleLBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorB.C. Cho-
dc.contributor.googleauthorM-J. Ahn-
dc.contributor.googleauthorJ.H. Kang-
dc.contributor.googleauthorR. Soo-
dc.contributor.googleauthorT. Baisamut (Reungwetwattana)-
dc.contributor.googleauthorJ.C-H. Yang-
dc.contributor.googleauthorI. Cicin-
dc.contributor.googleauthorD-W. Kim-
dc.contributor.googleauthorY-L. Wu-
dc.contributor.googleauthorS. Lu-
dc.contributor.googleauthorK. Lee-
dc.contributor.googleauthorY-K. Pang-
dc.contributor.googleauthorA. Zimina-
dc.contributor.googleauthorC.H. Fong-
dc.contributor.googleauthorE. Poddubskaya-
dc.contributor.googleauthorY. Kim-
dc.contributor.googleauthorT. An-
dc.contributor.googleauthorH. Lee-
dc.contributor.googleauthorH. Byun-
dc.contributor.googleauthorB. Zaric-
dc.identifier.doi10.1016/j.annonc.2022.10.349-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422045409-
dc.citation.volume33-
dc.citation.numberSuppl 9-
dc.citation.startPageS1560-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Suppl 9) : S1560, 2022-11-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.